Ligand binding and nuclear receptor evolution

BioEssays

Volumn 22, Issue 8, 2000, Pages 717-727

  Escriva, Hector ^a   Delaunay, Franck ^a   Laudet, Vincent ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; LIGAND;

ANIMAL; BIOLOGICAL MODEL; CLASSIFICATION; EVOLUTION; GENETICS; HUMAN; METABOLISM; PHYLOGENY; REVIEW;

ANIMALS; EVOLUTION; HUMANS; LIGANDS; MODELS, BIOLOGICAL; PHYLOGENY; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

ANIMALIA; METAZOA;

EID: 0033858499     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-1878(200008)22:8<717::AID-BIES5>3.0.CO;2-I     Document Type: Review

References (62)

1. Gronemeyer H, Laudet V. Transcription factors 3: Nuclear receptors. In Protein Profile, Vol. 2. Sheterline P (ed). London, Academic Press. 1995.
2. Gustafsson J-Å. Seeking ligands for lonely orphan receptors. Science 1999;284:1285-1286.
3. Moore DD. Diversity and unity in the nuclear hormone receptors: a terpenoid receptor superfamily. New Bid 2 1990;100-105.
4. Escriva H, Safi R, Hänni C, Langlois M-C, Saumitou-Laprade P, Sthéhelm D, Capron A, Pierce R, Laudet V. Ligand binding was acquired during evolution of nuclear receptors. Proc Natl Acad Sci USA 1997;94: 6803-6808.
5. Cooney AJ, Katz D, Hummelke GC, Jackson KJ. Germ cell nuclear factor: An orphan receptor in search of a function. Am Zool 1999;39: 796-806.
6. Vanacker JM, Bonnelye E, Chopin-Delannoy S, Delmarre C, Cavailles V, Laudet V. Transcriptional activities of the orphan nuclear receptor ERR alpha (estrogen receptor-related receptor-alpha). Mol Endocrinol 1999; 13:764-773.
7. Fondell JD, Roy AL, Roeder RG. Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: implications for active repression. Genes Dev 1993;7:1400-1410.
8. Hörlein AJ, När AM, Heinzel T, Torchia J, Gloss B, Kurukawa R, Ryan A, Kamei Y, Söderström M, Glass CK, Rosenfeld MG. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995;377: 397-404.
9. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 1995;375:377-382.
10. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engström O, Öhman L, Greene GL, Gustafsson J-Å, Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997;389: 753-758.
11. Renaud J-P, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D. Crystal structure of the RAR-g ligand binding domain bound to all-trans retinoic acid. Nature 1995;378:681-689.
12. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ. A structural role for hormone in the thyroid hormone receptor. Nature 1995;378:690-697.
13. Forman BM, Tzameli I, Choi H-S, Chen J, Simha D, Seol W, Evans RM, Moore DD. Androstane metabolites bind to and deactivate the nuclear receptor CAR-β. Nature 1998;395:612-615.
14. Amero SA, Kretsinger RH, Moncrief ND, Yamamoto KR, Pearson WR. The origin of nuclear receptor proteins: a single precursor distinct from other transcription factors. Mol Endocrinol 1992;6:3-7.
15. Detera-Wadleigh SD, Fanning TG. Phytogeny of the steroid receptor superfamily. Mol Phylogenet Evol 1994;3192-205.
16. Laudet V. Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor. J Mol Endocrinol 1997;19: 207-226.
17. Enmark E, Gustafsson J-A. Nematode genome sequence dramatically extend the nuclear receptor superfamily. Trends Pharmacol Sci 2000; 21:85-87.
18. Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999;97:161-163.
19. Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson NC, LeCluyse EL, Lambert MH, Willson TM, Kliewer SA, Moore JT. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol 2000;14:27-39.
20. Kostrouch Z, Kostrouchova M, Love W, Jannini E, Piatigorsky J, Rall EJ. Retinoic acid X receptor in the diploblast, Tripedalia cystophora. Proc Natl Acad Sci USA 1998;95:13442-13447.
21. Thornton JW, Kelley DB. Evolution of the androgen receptor: structure-function implications. Bioessays 1998;20:860-869.
22. Bogan AA, Cohen FE, Scanlan TS. Natural ligands of nuclear receptors have conserved volumes. Nat Struct Biol 1998;5:679-681.
23. Nolle RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 1998;395:137-143.
24. Madani ND, Malloy PJ, Rodriguez-Pombo P, Krishnan AV, Feldman D. Candida albicans estroger-binding protein gene encodes an oxidoreductase that is inhibited by estradiol. Proc Natl Acad Sci USA 1994;91:922-926.
25. Altmann T. A tale of dwarfs and drugs: brassinosteroids to the rescue. Trends Genet 1998;14:490-495.
26. Jizba J, Herout V, Sorm F. Isolation of ecdysterone (crustecdysone) from Polypodium vulgare L. rhizomes. Tetrahedron Lett 1967;18:1689-1691.
27. Nirde P, Torpier G, De Reggi ML, Capror A. Ecdysone and 20 hydroxyecdysone: new hormones for the human parasite schistosoma mansoni. FEBS Lett 1983;151:223-227.
28. Aguinaldo AM, Turbeville JM, Linford LS, Rivera MC, Garey JR, Raff RA, Lake JA. Evidence for a clade of nematodes, arthropods and other moulting animals. Nature 1997;387:489-493.
29. Mendonca RL, Escriva H, Vanacker JM, Bouton D, Delannoy S, Pierce R, Laudet V. Nuclear hormone receptors and evolution. Am Zool 1999;39: 704-713.
30. Carosa E, Fanelli A, Ulisse S, Lauro RD, Rall EJ, Jannini EA. Ciona intestinalis nuclear receptor 1: A member of steroid/thyroid hormone receptor family. Proc Natl Acad Sci USA 1998;95:11152-11557.
31. Fredriksson G, Lebel JM, Leloup J. Thyroid hormones and putative nuclear T3 receptors in tissues of the ascidian, Phallusia mammillata cuvier. Gen Comp Endocrinol 1993;92:379-387.
32. Horn F, Bywater R, Krause G, Kuipers W, Oliveira L, Paiva AC, Sander C, Vriend G. The interaction of class B G protein-coupled receptors with their hormones. Receptors Channels 1998;5:305-314.
33. Vernier P, Cardinaud B, Valdenaire O, Philippe H, Vincent JD. An evolutionary view of drug-receptor interaction: the bioamine receptor family. Trends Pharmacol Sci 1995;16:375-381.
34. Hahn ME, Karchner SI, Shapiro MA, Perera SA. Molecular evolution of two vertebrate aryl hydrocarbon (dioxin) receptors (AHR1 and AHR2) and the PAS family. Proc Natl Acad Sci U S A 1997;94:13743-13748.
35. Moyle WR, Campbell RK, Myers RV, Bernard MP, Han Y, Wang X. Coevolution of ligand-receptor pairs. Nature 1994;368:251-255.
36. Zhang C, Anderson A, DeLisi C. Structural principles that govern the peptide-binding motifs of class I MHC molecules. J Mol Biol 1998;281: 929-947.
37. van Kesteren RE GW. Molecular evolution of ligand-binding specificity in thevasopressin/oxytocin receptor family. Ann NY Acad Sci 1998;839:25-34.
38. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem 1981;50:465-495.
39. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 1992;267:16283-16287.
40. Vilcek J, Lee TH. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 1991;266:7313-7316.
41. Fryxell KJ. The coevolution of gene family trees. Trends Genet 1996; 12:364-369.
42. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L. Nuclear receptor coactivators and corepressor. Mol Endocrinol 1996;10: 1167-1177.
43. Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H. A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 1996;3:87-94.
44. Garcia-Vallvé S, Palau J. Nuclear receptors, nuclear-receptor factors, and nuclear-receptor-like orphans form a large paralog cluster in Homo sapiens. Mol Biol Evol 1998;15:665-682.
45. Cenni B, Picard D. Ligand-independent activation of steroid receptors new roles for old players. Trends Endocinol Metab 1998;10:41-46.
46. Curtis SW, Washburn T, Sewall C, DiAugustine R, Lindzey J, Couse JF, Korach KS. Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc Natl Acad Sci USA 1996;93: 12626-12630.
47. Bunone G, Briand PA, Miksicek RJ, Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 1996;15:2174-2183.
48. Weis KE, Ekena K Thomas JA, Lazennec G, Katzenellenbogen BS. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol Endocrinol 1996;10:1388-1398.
49. Shao D, Rangwala SM, Bailey ST, Krakow SL, Reginato MJ, Lazar MA. Interdomain communication regulating ligand binding by PPAR-gamma. Nature 1998;396:377-380.
50. Hirata Y, Kiuchi K, Chen HC, Milbrandt J, Guroff G. The phosphorylation and DNA binding of the DNA-binding domain of the orphan nuclear receptor NGFI-B. J Biol Chem 1993;268:24808-24812.
51. Li Y, Lau LF. Adrenocorticotropic hormone regulates the activities of the orphan nuclear receptor Nur77 through modulation of phosphorylation Endocrinology 1997;138:4138-4146.
52. Mani SK, Allen JM, Lydon JP, Mulac-Jericevic B, Blaustein JD, DeMayo FJ, Conneely O, O'Malley BW. Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice. Mol Endocrinol 199310:1728-1737.
53. Tremblay JJ, Marcil A, Gauthier Y, Drouin J. Ptx1 regulates SF-1 activity by an interaction that mimics the role of the ligand-binding domain. EMBO J 1999;18:3431-3441.
54. Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J. Bernards R, Michalides RJ. CDK-independent activation of estrogen receptor by cyclin D1. Cell 1997;88:405-415.
55. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-895.
56. O'Malley BW. Did eucaryotic steroid receptors evolve from intracrine gene regulators? Endocrinology 1989;125:1119-1120.
57. Shenk MA, Steele RE. (1993). A molecular snapshot of the metazoan 'Eve'. Trends Biochem Sci 1993;18:459-463.
58. Goffeau A. The yeast genome directory. Nature 1997;387:1-105.
59. Muchardt C, Yaniv M. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocolicoid receptor. EMBO J 1993;11: 4279-4290.
60. Baniahmad C, Nawaz Z, Baniahmad A, Gleeson MAG, Tsai M-J, O'Malley BW. Enhancement of human estrogen receptor activity by SPT6: A potential coactivator. Mol Endocrinol 1995;9:34-43.
61. vom Baur E, Harbers M, Um SJ, Benecke A, Chambon P, Losson R. The yeast Ada complex mediates the ligand-dependent activation function AF-2 of retinoid X and estrogen receptors. Geres Dev 1998; 12:1278-1289.
62. 2+/calmodulin dependent protein kinase IV. EMBO J 2000; 19:691-701.